While reporting financial results for the second quarter, Alexion Pharmaceuticals, Inc. (ALXN) on Wednesday raised its adjusted earnings and revenue guidance for the full year 2019 to reflect strength of the business and continued growth.
from RTT - Earnings https://ift.tt/2yiUhNz
via IFTTT
No comments:
Post a Comment